| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916037 | Nuclear Medicine and Biology | 2014 | 8 Pages |
Abstract
The radiolanthanide 155Tb may be of particular interest for low-dose SPECT prior to therapy with a therapeutic match such as the β--emitting radiolanthanides 177Lu, 161Tb, 166Ho, and the pseudo-radiolanthanide 90Y.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cristina Müller, Eliane Fischer, Martin Behe, Ulli Köster, Holger Dorrer, Josefine Reber, Stephanie Haller, Susan Cohrs, Alain Blanc, Jürgen Grünberg, Maruta Bunka, Konstantin Zhernosekov, Nicholas van der Meulen, Karl Johnston, Andreas Türler,